Nov 5 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2021 Sep 30, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 253 mln 247 mln 770 mln
(+2.4 pct) (+7.4 pct) (+27.7 pct)
Operating loss 136 mln loss 177 mln loss 107 mln
Recurring loss 188 mln loss 227 mln loss 154 mln
Net loss 199 mln loss 230 mln loss 162 mln
EPS loss 21.40 yen loss 24.75 yen loss 17.42 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T